References
1) National Service Framework for Diabetes in Wales : Delivery Strategy. National Assembly Government www.wales.gov.uk
2) WHO 1999. Definition, diagnosis and classification of Diabetes Mellitus and its complications. Part1: Diagnosis and classification of Diabetes Mellitus. World Health Organisation Department of noncommunicable disease surveillance, Geneva . www.euro.who.int
3) Prochaska JO, DiClemente CC. "Towards a comprehensive model of change" in: Miller WR and Heather N (eds). Treating addictive behaviour: processes of change . Plenum, New York , 1986
4) Nutrition Subcommittee, British Diabetic Association. Dietary recommendations for diabetics for the 1980's. Human Nutrition: Applied Nutrition 1982; 36A : 378-394.
5) Nutrition Subcommittee, British Diabetic Association. Dietary Recommendations for people with diabetes: an update for the 1990's. Diabetic Medicine 1992; 9 :189-2002.
6) The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Recommendations for the nutritional treatment of patients with diabetes mellitus. European Journal of Clinical Nutrition 2000; 54 :353-355.
7) American Diabetes Association. Evidence-based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and related Complications. Diabetes Care 2002; 26 :148-198.
8) Nutrition Subcommittee, Diabetes UK . The Implementation of nutritional advice for people with diabetes. Diabetic Medicine 2003; 20 :786-807.
9) Scottish Intercollegiate Guidelines Network (November 2001). Management of Diabetes, A National Clinical Guideline www.sign.ac.uk/guidelines
10) DCCT Research Group. The effect of Intensive Treatment of Diabetes on the development and progression of long term complications in Insulin Dependant Diabetes . New England Journal of Medicine 1993; 329 : 977-986.
11) UK Prospective Diabetes Study Group (UKPDS 7). Response of fasting plasma glucose to diet therapy in newly presenting Type 2 diabetes. Metabolism 1990; 39 : 905-912.
12) Scottish Intercollegiate Guidelines Network (1996). Obesity in Scotland : integrating prevention with weight management www.sign.ac.uk/guidelines
13) Health Education Authority (1995) Becoming more active- a guide for Health Professionals . HEA, London
14) Department of Health (1996) Strategy Statement on Physical Activity . Department of Health, London
15) DTC Primary Care Training Centre (2001) Diploma in Coronary Heart Disease Prevention in Primary Care . St. Leonards Press, Yorkshire .
16) Diabetes UK (2003) Care Recommendation Physical Activity and Diabetes. www.diabetes.org.uk
17) The Gayton Group GP Exercise Referral Certificate Course Manual. The Gayton Group
18) BouchardC. and Despres J.P. Physical activity and health: Atherosclerotic, metabolic and hypertensive diseases . Conference notes from International Scientific Consensus Conference 1995. Quebec City
19) Knowler W.C., Barrett-Conner, E. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine 2002; 346 :393-403.
20) Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002; 346 : 393-403
21) Lampman R.M. and Schteingart D.E. (1991) Effects of exercise training on glucose control, lipid metabolism and insulin sensitivity in hypertriglyceridemis and non insulin dependent diabetes mellitus. Med. Sci Sports Exercise 1991; 23 :703-712.
22) Presidents Council on Physical Fitness and Sports. Physical activity and the prevention of type 2 (Non insulin dependent) diabetes. Research Digest 2000; 2
23) Berlin J.A. and Colditz G.A. A meta analysis of physical activity in the prevention of coronary heart disease. American Journal of Epidemiology 1990; 132 : 612-28
24) Shaper A.G. and Wannamethee G. Physical Activity and ischaemic heart disease in middle aged British men. British Heart Journal 1991; 66: 384-94
25) Wannamethee G., and Shaper A.G. Physical activity and stroke in British middle aged men. BMJ 1992; 304 : 597-601
26) Stefanick M.L. et al. Effects of Diet and Exercise in men and post menopausal women with low levels of HDL and high levels of LDL cholesterol. New Eng J Med 1998; 339 : 12-20
27) Tipton C.M. et al. Influences of exercise intensity, age, and medication on resting blood pressure in SHR populations. Journal of Applied Physiology 1995; 55: 1305-1310
28) Ross R. et al. Exercise alone is an effective strategy for reducing obesity and related co morbidities. Exercise and Sport Science Review 2000; 28: 165-170
29) Rejeski W.J., et al. Acute exercise: buffering psychological stress responses in women. Health Psychology 1992; 11 : 355-362
30) Vaserling J.J., Sementilli M.E. and Burish T.G. The role of aerobic exercise in reducing stress in diabetic patients . Diabetes Educator 1988; 14 : 197-201.
31) National Institute for Clinical Excellence - Guidance on the use of nicotine replacement therapy and bupropion for smoking cessation. www.nice.org.uk
32) Callum C. The UK smoking epidemic: deaths in 1995. London Health Education Authority 1998
33) Department of Health, Department of Health and Social Services (Northern Ireland), the Scottish Office Department of Health, Welsh Office. The report of the Scientific Committee on Tobacco and Health 1998 www.official-documents.co.uk/documents/doh/tobacco/report.htm
34) Nicotine Addiction in Britain . A report of the Tobacco Advisory Group of the Royal College of Physicians. Royal College of Physicians 2000
35) Kawakami N. et al. Effects of smoking on incidence of non-insulin dependence diabetes mellitus. American Journal of Epidemiology 1997; 145 : 103-109
36) Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epdemiol 1984; 120 : 670-675
37) Targher G. et al . Cigarette smoking and insulin resistance in patients with non-insulin dependent diabetes mellitus, J. Clin Endocrin Metab 1997; 82 : 3619-3624
38) Wannamethee SG. Shaper AG. and Pery IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 2001; 24 : 1590-1595
39) Raw M., McNeill A. and West R. Smoking cessation guidelines for health professionals. Thorax 1998; 53 (suppl) ;S1-19
40) Wanless D. Securing our future health: taking a long term view (interim report). 2002; HM Treasury , London .
41) Milner D. and Bates C. Smoking interventions in the new GP contract. Action on Smoking and Health , 2002
42) Parrott S., Godfrey C. et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax 1998; 59 (suppl) .
43) Monnier L. Glucose monitoring revisited: Past-Present-Future. Diabetes and Primary Care 2003; 5 :140-143
44) National Diabetes Support Team. Glucose Self Monitoring in Diabetes. NICE Guidelines 2003 ; Fact Sheet 1
45) Burrill P. Is self monitoring of glycaemic control of any value?. The Pharmaceutical Journal 2002 ; 268 : 847-848
46) Owens D. et al. Blood glucose self-monitoring in Type1 and Type 2 diabetes: reaching a multidisciplinary consensus. Diabetes and Primary care 2004 ; 6 : 8-16
47) European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabetic Medicine 1999; 16 :716-730
48) British National Formulary. Section 6.1.2. British Medical Association London www.BNF.org
49) Stratton I.M. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) Prospective observational study BMJ 2000; 321 : 405-412
50) National Institute of Clinical Excellence. Management of type 2 diabetes-Blood glucose Management. Sept 2002 www.nice.org.uk
51) Diabetes UK 2004. Driving and diabetes. www.diabetes.org.uk
52) Guidelines for Management of Hypertension: report of the fourth working party of the British Hypertension Society 2004 - BHS IV. Journal of Human Hypertension 2004; 18 : 139-185
53) Monthly Index of Medical Specialities. Section 2H. Haymarket Medical Publications London. www.emims.net
54) Heart protection Study Group MRC / BHF Heart Protection Study of cholesterol lowering with simvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in Anglo-Scandinavian Cardiac Outcomes Trial-Lipid lowering arm (ASCOT-LLA), a multi-centre randomised controlled trial. Lancet 2003; 361 :1149-1158
55) European Society of Hypertension/ European Society of Cardiology Guidelines for the management of Arterial Hypertension. Journal of Hypertension 2003; 21 :1101-1053
56) Lehto S., Ronnemaa T. et al. Predictors of stroke in middle-aged patients with NIDDM. Stroke 1996; 27 : 63-68.
57) Davies T.M.E., Millns H. et al. Risk Factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Archives Intern Med 1999; 159 :1097-1103
58) Guerrero-Romero F. and Rodriguez-Moran M. Proteinuria is an independent risk factor for ischaemic stroke in Non-Insulin-Dependent diabetes mellitus. Stroke 1999; 30 :1787-1791
59) UKPDS (38) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; 317 :703-713
60) Colwell J.A. Aspirin therapy in diabetes. Diabetes Care 1997; 20 :1767-1771
61) Collins R., Armitage J. et al. Heart Protection StudyCollaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361 :2005-2016.
62) American Diabetes Association. Peripheral Arterial Disease in People with Diabetes. Diabetes Care 2003; 26 :3333-3342